Former Liberal health minister Greg Hunt, who oversaw Australia’s response to the COVID-19 pandemic, has been appointed to the board of a private Sydney company developing drugs to combat rare blood diseases.
HaemaLogiX chief executive Damian Clarke-Bruce said in a press release that Mr Hunt’s appointment “further links us internationally with key industry stakeholders”.
Loading...
Aaron Patrick was a senior correspondent at The Australian Financial Review.
